Dr Kaushik Patel BMedSci, MB ChB, FRCPath
Consultant Medical Director & Cellular Pathologist
Dr Kaushik R Patel is a Fellow of the Royal College of Pathologists with over 24 years' experience as a Consultant Cellular Pathologist in the NHS and private sector. He obtained a bachelor’s degree in medical sciences related to pathology and a medical degree from Sheffield Medical School (1987). He undertook postgraduate training in Sheffield, Watford and Leeds prior to being appointed as a Consultant Cellular Pathologist at Queen Mary’s Hospital, Roehampton (1996) and subsequently transferred to Kingston Hospital (1998). He has served as lead in a variety of pathology disciplines including Cellular Pathology, Cervical Cytology Screening for the NHSCSP (including Hospital Based Coordinator) and has been a Designated Individual for the Human Tissue Act. He has extensive experience in the provision of cellular pathology diagnostic and cancer screening services and has a particular interest in IT related to pathology and in quality assurance systems. As well as being a general histopathologist, he has a specialist interest in gynaecological pathology and medical histopathology including liver diseases.
Dr Elli Demertzi MD PhD FRCPath
Dr Elli Demertzi qualified from Athens National University Medical School, Greece (1989), gained
a PhD in Clinical Microbiology and completed her specialty training in Medical Microbiology,
Pathology in Athens. She undertook post-doctoral research in Molecular bacterial typing in
PHLS, Central Public Health Laboratory, London (1999-2000).
She is a Consultant Microbiologist and Lead Infection Control Doctor at Kingston Hospital NHS Foundation Trust. She has over 20 years experience as a specialist in Infection diagnosis and management with interests in molecular diagnostics, Point of Care Testing, nosocomial infections and OPAT.
Dr John Bolodeoku MBBS, MSc, MBA, DPhil, FRCPath
Consultant Chemical Pathologist
John is a Chemical Pathologist and Pharmaceutical Medicine Physician starting working in the NHS as a Senior House Officer in General Medicine in Seacroft Killingbeck Hospital, Leeds and Sutton Hospital, Senior House Officer in Chemical Pathology in St. Helier, Registrar in Chemical Pathology at St Helier and St Georges Hospital Medical School, London. Pursued a Doctorate in Molecular Pathology at the John Radcliffe Hospital, Oxford, returned to London as Senior Registrar/Lecturer in Chemical Pathology at the Royal Free Hospital Medical School, London. He completed specialist training in 1997 in Chemical Pathology, then worked as Locum Consultant Chemical Pathologist at Farnborough Hospital and in 1999 was appointed Honorary Consultant Physician (Cardiology-Lipids) at North Hampshire Hospital, Basingstoke where he holds outpatient clinic sessions. He started working in the pharmaceutical industry in 1997. Over the years he has held positions in Clinical Research and Medical Affairs in several companies in the UK and Europe: BIOS (Consultancy & Research Organization), Pfizer, Yamanouchi, Astellas, Daichii Sankyo, Biogen Idec, Roche, NAPP, ICON Solutions, Eli Lilly and Celgene. Currently, he provides pathology consultancy and pharmaceutical medical marketing services to laboratories, pharmaceutical and device companies. He has a passion for “bringing diagnostics closer to the customer” and integrating diagnostic and pharmaceuticals. He loves Point of Care Testing (POCT) and self testing devices.
Dr Simon Stern
Dr Stern has been a Consultant Haematologist since 1999, initially at Surrey and Sussex Healthcare NHS Trust, and since 2010 at Epsom and St Helier University Hospitals NHS Trust. Since 2018 he has been an Honorary Consultant Haematologist at the Royal Marsden Hospital NHS Foundation Trust. He has a broad clinical experience in all aspects of clinical and laboratory haematology, but his main interests are in the field of the haematological malignancies. He has been Clinical Lead for Pathology at both the Trusts at which he has worked, and for 3 years was Lead Clinician for the joint haemato-oncology multi-disciplinary team involving Epsom and St Helier, the Royal Marsden and Croydon University Hospitals. He is currently Clinical Lead for Chemotherapy at Epsom and St Helier University Hospitals NHS Trust. Externally he is Chair of the UK Myeloma Forum Guidelines Group, and also a member of the British Society for Haematology Haemato-oncology Task Force and the Myeloma UK Early Diagnosis Steering Committee.
Dr Tom Van den Bossche MD
Consultant General Practitioner & Patient Results
Dr Tom Van den Bossche qualified from Ghent Medical School in Belgium (1988) and studied Tropical Medicine at the Antwerp Tropical Institute (1989). He undertook his GP vocational training in Belgium before leaving the country to work abroad. He worked and lived in South Africa for 8 years—mainly at Chris Hani Hospital in Soweto, Johannesburg and at Red Cross Children’s Hospital in Cape Town. He worked in China for more than 2 years after completing the Chinese Medical Board Exam. He worked as a GP in various central Asian countries, including Kazakhstan, Azerbaijan and Indonesia, as well as the African countries Nigeria, Mali and Chad. Before settling in London in 2005, he worked in Paris for just over 2 years. Throughout his career he has also learnt to speak 5 different languages.